Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Frontiers | How Should We Classify Kawasaki Disease?
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Kawasaki Disease
Children | Free Full-Text | Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Recurrent Kawasaki disease | British Dental Journal
Frontiers | Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - ScienceDirect
Children | Free Full-Text | Major Complication Following Kawasaki Disease in an Infant—The Development of Apical Infarction and Aneurysm Formation
Recurrence of Kawasaki Disease: Look Before you Leap on the Bandwagon Recurrence of Kawasaki Disease: Authors' Reply
Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight | Nature Reviews Microbiology
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study | PLOS ONE
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease - Masanori Yoshida, Shinji Oana, Hiroshi Masuda, Akira Ishiguro, Hitoshi Kato, Shuichi Ito, Tohru Kobayashi, Jun Abe, 2018
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Frontiers | How Should We Classify Kawasaki Disease?